GRABODY

What this means for you

Registered since 09 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

88843068

Registration number

6550037

Mark type

Design + words

Filed

21 Mar 2020

Published for opposition

24 Aug 2021

Registered

09 Nov 2021

Attorney of record

Steven J. Hultquist

Goods and services

• Class 005 — Pharmaceuticals: ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions, namely, pharmaceutical preparations for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases
• Class 042 — Scientific and technological services: scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, namely, conducting testing in the nature of clinical trials of medicines for others; medical and scientific research, namely, conducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals

Owner

• ABL Bio, Inc., Gyeonggi-do, KR
• ABL Bio, Inc., Gyeonggi-do, KR
• ABL Bio, Inc., Gyeonggi-do, KR

Prosecution history

• 09 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
• 24 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Aug 2021 — PUBLISHED FOR OPPOSITION
• 04 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 20 Jul 2021 — CASE RETURNED TO EXAMINATION
• 20 Jul 2021 — NOTICE OF ALLOWANCE CANCELLED
• 12 Jul 2021 — ASSIGNED TO PETITION STAFF
• 25 Jun 2021 — TEAS PETITION TO AMEND BASIS RECEIVED
• 24 Jun 2021 — TEAS PETITION TO AMEND BASIS RECEIVED
• 09 Mar 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 24 Jan 2021 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
• 15 Oct 2020 — EXTENSION OF TIME TO OPPOSE RECEIVED
• 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 15 Sept 2020 — PUBLISHED FOR OPPOSITION
• 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED